Mesirow Financial Investment Management - Fixed Income’s Avanos Medical AVNS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-5,970
Closed -$200K 124
2022
Q1
$200K Sell
5,970
-70
-1% -$2.25K 0.02% 122
2021
Q4
$209K Hold
6,040
0.02% 129
2021
Q3
$188K Buy
+6,040
New +$205K 0.02% 127

Other funds holding AVNS

Mesirow Financial Investment Management - Fixed Income's AVNS Position: Q2 2022 in Review

Mesirow Financial Investment Management - Fixed Income sold out of Avanos Medical (AVNS) in Q2 2022, closing a stake of 5,970 shares — an estimated $200K sold.

Mesirow Financial Investment Management - Fixed Income first reported a position in AVNS in Q3 2021 and held it in 3 quarters. The position peaked at $209K in Q4 2021. 287 funds tracked by Wall St. Rank hold AVNS as of Q2 2022.

  • Mesirow Financial Investment Management - Fixed Income reported no remaining Avanos Medical position as of Q2 2022 after selling out during the quarter.
  • Mesirow Financial Investment Management - Fixed Income sold 5,970 Avanos Medical shares in Q2 2022, an estimated $200K.
  • Mesirow Financial Investment Management - Fixed Income first reported a position in Avanos Medical in Q3 2021 and held it in 3 quarters.
  • Mesirow Financial Investment Management - Fixed Income's Avanos Medical position peaked at $209K in Q4 2021.
  • 287 funds tracked by Wall St. Rank held Avanos Medical as of Q2 2022.

Based on Mesirow Financial Investment Management - Fixed Income's 13F filing for Q2 2022, filed 8 Aug 2022.